Heron Therapeutics’ Cooperation Agreement with Rubric Capital and Velan Capital

Kirkland & Ellis advised Heron Therapeutics on the deal.Heron Therapeutics, Inc. (NASDAQ: HRTX) announced that it has entered into a cooperation agreement with two of its shareholders,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Pietro Martinoia

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here